Rockefeller Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,085
| Closed | -$275K | – | 2050 |
|
|
2023
Q1 | $275K | Buy |
5,085
+1,519
| +43% | +$82.1K | ﹤0.01% | 1632 |
|
|
2022
Q4 | $188K | Buy |
3,566
+74
| +2% | +$3.9K | ﹤0.01% | 1695 |
|
|
2022
Q3 | $162K | Buy |
3,492
+3,274
| +1,502% | +$152K | ﹤0.01% | 1745 |
|
|
2022
Q2 | $12K | Buy |
218
+192
| +738% | +$10.6K | ﹤0.01% | 3039 |
|
|
2022
Q1 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 3800 |
|